Effects of topical application of α-D-glucosylglycerol on dermal levels of insulin-like growth factor-I in mice and on facial skin elasticity in humans

Bioscience, Biotechnology and Biochemistry

Volumn 74, Issue 4, 2010, Pages 759-765

  Harada, Naoaki ^a   Zhao, Juan ^a   Kurihara, Hiroki ^b   Nakagata, Naomi ^c   Okajima, Kenji ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c KUMAMOTO UNIVERSITY   (Japan)

Author keywords

D glucosylglycerol; Calcitonin gene related peptide; Insulin like growth factor I; Sensory neurons; Skin elasticity

Indexed keywords

CALCITONIN GENE-RELATED PEPTIDES; DORSAL ROOT GANGLION NEURONS; FACIAL SKIN; INSULIN-LIKE GROWTH FACTOR-I; KNOCKOUT MICE; PRE-TREATMENT; PROTEIN KINASE A; RICE WINE; SENSORY NEURONS; SKIN ELASTICITY; TOPICAL APPLICATION; VANILLOID RECEPTOR; WILD TYPES;

BIOACTIVITY; ELASTICITY; FETAL MONITORING; INSULIN; NEURONS; PEPTIDES; WINE;

SKIN;

CAPSAICIN; CAPSAZEPINE; CARBAZOLE DERIVATIVE; DRUG DERIVATIVE; GLUCOSIDE; GLUCOSYLGLYCEROL; KT 5720; MESSENGER RNA; PYRROLE DERIVATIVE; SOMATOMEDIN C; VANILLOID RECEPTOR; VANILLOID RECEPTOR SUBTYPE 1;

ANIMAL; ARTICLE; BIOSYNTHESIS; C57BL MOUSE; DERMIS; DRUG EFFECT; ELASTICITY; FACE; FEMALE; GENE; GENETICS; HUMAN; MALE; METABOLISM; MOUSE; MOUSE MUTANT; SENSORY NERVE CELL; SENSORY RECEPTOR; SKIN; SPINAL GANGLION; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANIMALS; CAPSAICIN; CARBAZOLES; DERMIS; ELASTICITY; FACE; FEMALE; GANGLIA, SPINAL; GENES; GLUCOSIDES; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEURONS, AFFERENT; PYRROLES; RNA, MESSENGER; SENSORY RECEPTOR CELLS; SKIN; TRPV CATION CHANNELS;

MUS; ORYZA SATIVA (JAPONICA CULTIVAR-GROUP);

EID: 77951595226     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.90797     Document Type: Article

References (38)

1. Daughaday WH and Rotwein P, Endocr. Rev., 10, 68-91 (1989).
2. Tavakkol A, Varani J, Elder JT, and Zouboulis CC, Arch. Dermatol. Res., 291, 643-651 (1999).
3. Harrison CA, Gossiel F, Bullock AJ, Sun T, Blumsohn A, and Mac Neil S, Br. J. Dermatol., 154, 401-410 (2006).
4. Maggi CA and Meli A, Gen. Pharmacol., 19, 1-43 (1988).
5. Dray A, Br. J. Anaesth., 75, 125-131 (1995).
6. Rosenfeld MG, Mermod JJ, Amara SG, Swanson LW, Sawchenko PE, Rivier J, Vale WW, and Evans RM, Nature, 304, 129-135 (1983).
7. Harada N, Okajima K, Kurihara H, and Nakagata N, Neuropharmacology, 52, 1303-1311 (2007).
8. Harada N and Okajima K, Growth Horm. IGF Res., 17, 171-176 (2007).
9. Harada N, Okajima K, Arai M, Kurihara H, and Nakagata N, Growth Horm. IGF Res., 17, 408-415 (2007).
10. Nakahara M, Mishima T, and Hayakawa T, Biosci. Biotechnol. Biochem., 71, 427-434 (2007).
11. Kitamura N, Ota Y, Haratake A, Ikemoto T, Tanno O, and Horikoshi T, Skin Pharmacol., 10, 153-159 (1997).
12. Hirotsune M, Haratake A, Komiya A, Sugita J, Tachihara T, Komai T, Hizume K, Ozeki K, and Ikemoto T, J. Agric. Food Chem., 53, 948-952 (2005).
13. Takenaka F, Uchiyama H, and Imamura T, Biosci. Biotechnol. Biochem., 64, 378-385 (2000).
14. Mackay MA, Norton RS, and Borowitzka L, J. Gen. Microbiol., 130, 2177-2191 (1984).
15. Perkins MN and Campbell EA, Br. J. Pharmacol., 107, 329-333 (1992).
16. Oh-hashi Y, Shindo T, Kurihara Y, Imai T, Wang Y, Morita H, Imai Y, Kayaba Y, Nishimatsu H, Suematsu Y, Hirata Y, Yazaki Y, Nagai R, Kuwaki T, and Kurihara H, Circ. Res., 89, 983-990 (2001).
17. Harada N, Okajima K, Uchiba M, Kurihara H, and Nakagata N, Thromb. Haemost., 95, 788-795 (2006).
18. Mohapatra DP and Nau C, J. Biol. Chem., 278, 50080-50090 (2003).
19. Hou L and Wang X, J. Neurosci. Res., 66, 592-600 (2001).
20. Sirotkin AV, Florkovicova I, Makarevich AV, Schaeffer HJ, Kotwica J, Marnet PG, and Sanislo P, J. Reprod. Dev., 49, 141-149 (2003).
21. Geppetti P, Tramontana M, Evangelista S, Renzi D, Maggi CA, Fusco BM, and Del Bianco E, Gastroenterology, 101, 1505-1511 (1991).
22. Tomomasa T, Ogawa T, Hikima A, Tabata M, Kaneko H, and Morikawa A, J. Pediatr. Gastroenterol. Nutr., 34, 169-173 (2002).
23. Junquiera LC, Junqueira LC, and Brentani RR, Anal. Biochem., 94, 96-99 (1979).
24. Joseph J, Joseph L, Shekhawat NS, Devi S, Wang J, Melchert RB, Hauer-Jensen M, and Kennedy RH, Am. J. Physiol. Heart Circ. Physiol., 285, H679-H686 (2003).
25. Sumino H, Ichikawa S, Abe M, Endo Y, Nakajima Y, Minegishi T, Ishikawa O, and Kurabayashi M, Endocr. J., 51, 159-164 (2004).
26. Schnizler K, Shutov LP, van Kanegan MJ, Merrill MA, Nichols B, McKnight GS, Strack S, Hell JW, and Usachev YM, J. Neurosci., 28, 4904-4917 (2008).
27. Zhao J, Harada N, Kurihara H, Nakagata N, and Okajima K, Neuropharmacology, in press.
28. Okajima K and Harada N, Curr. Med. Chem., 13, 2241-2251 (2006).
29. Hodak E, Gottlieb AB, Anzilotti M, and Krueger JG, J. Invest. Dermatol., 106, 564-570 (1996).
30. Tavakkol A, Elder JT, Griffiths CE, Cooper KD, Talwar H, Fisher GJ, Keane KM, Foltin SK, and Voorhees JJ, J. Invest. Dermatol., 99, 343-349 (1992).
31. Vignery A and McCarthy TL, Bone, 18, 331-335 (1996).
32. Davidson JM, Zoia O, and Liu JM, J. Cell. Physiol., 155, 149-156 (1993).
33. Krane JF, Murphy DP, Carter DM, and Krueger JG, J. Invest. Dermatol., 96, 419-424 (1991).
34. Laron Z, J. Clin. Endocrinol. Metab., 89, 1031-1044 (2004).
35. Pierard G, "Cutaneous Investigation in Health and Disease," ed. Leveque T, Dekker, New York, pp. 215-240 (1989).
36. Pedersen SA, Welling K, Michaelsen KF, Jorgensen JO, Christiansen JS, and Skakkebaek NE, Lancet, 2, 681-682 (1989).
37. Lange M, Thulesen J, Feldt-Rasmussen U, Skakkebaek NE, Vahl N, Jorgensen JO, Christiansen JS, Poulsen SS, Sneppen SB, and Juul A, Eur. J. Endocrinol., 145, 147-153 (2001).
38. Serban G, Edelberg M, Garcia M, and Hambridge A, Bioeng. Skin, 2, 134 (1986).